|
Volumn 31, Issue 4, 2016, Pages 943-944
|
Subcutaneous tuberculosis formation during FOLFIRI and bevacizumab treatment: a case report
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADHESIVE AGENT;
BEVACIZUMAB;
CAPECITABINE;
FLUOROURACIL;
FOLINIC ACID;
IODINE;
IRINOTECAN;
ISONIAZID;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXALIPLATIN;
PSEUDOMONIC ACID;
PYRAZINAMIDE;
RALTITREXED;
RIFAPENTINE;
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
ABDOMINAL CAVITY;
ADULT;
ARTHRALGIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER REGRESSION;
CASE REPORT;
CLAVICLE;
COLON ADENOCARCINOMA;
COLON RESECTION;
DEBRIDEMENT;
DRUG WITHDRAWAL;
FALLOPIAN TUBE;
FEMALE;
FOAM DRESSING;
GENE MUTATION;
HUMAN;
HUMAN TISSUE;
LAPAROSCOPIC SURGERY;
LETTER;
LIVER METASTASIS;
LUNG METASTASIS;
MANUBRIUM;
MULTIPLE CYCLE TREATMENT;
MYCOBACTERIUM TUBERCULOSIS;
ONCOGENE K RAS;
PRIORITY JOURNAL;
RADICAL RESECTION;
RADIOFREQUENCY ABLATION;
RHEUMATOID ARTHRITIS;
STERNUM;
SUBCUTANEOUS NODULE;
SUBCUTANEOUS TUBERCULOSIS;
TOE;
TREATMENT OUTCOME;
TUBERCULIN TEST;
TUBERCULOSIS;
ULCER;
ULCER HEALING;
ANALOGS AND DERIVATIVES;
CHEMICALLY INDUCED;
PATHOLOGY;
SUBCUTANEOUS TISSUE;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BEVACIZUMAB;
CAMPTOTHECIN;
FEMALE;
FLUOROURACIL;
HUMANS;
LEUCOVORIN;
SUBCUTANEOUS TISSUE;
TUBERCULOSIS;
|
EID: 84939817233
PISSN: 01791958
EISSN: 14321262
Source Type: Journal
DOI: 10.1007/s00384-015-2368-6 Document Type: Letter |
Times cited : (2)
|
References (0)
|